As of 2024-12-14, the Fair Value of Modus Therapeutics Holding AB (MODTX.ST) is -2.09 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.60 SEK, the upside of Modus Therapeutics Holding AB is -230.47%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -43.58 | -6.02 | -20.69 | -18.32 | -17.90 | -21.30 |
| YoY growth | 12.23% | 86.19% | -243.69% | 11.45% | 2.31% | -26.30% |
| Market Cap (mil) | 57.50 |
| P/E | |
| Forward P/E |
| EPS | -0.42 |
| Avg earnings growth rate | -26.30% |
| TTM earnings | -15.01 |